TipRanks
55% OFF
PC:KINEA

Kinea Bio Inc

Kinea Bio Inc. is a biotechnology company specializing in the development of innovative genetic medicines using a novel dual AAV vector platform, SIMPLI-GT™, to deliver large therapeutic genes that exceed the natural packaging capacity of AAVs. The company focuses on systemic disorders such as Duchenne muscular dystrophy and dysferlinopathy, aiming to translate breakthrough biology into transformative treatments for patients with high unmet medical needs through strategic collaborations and cutting-edge science.

Leadership & Board

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$1M
Total Funding Rounds
1
Latest Funding Amount
$1M
Latest Funding Round
Investment
Post-Money Valuation
―

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 23, 2025Investment$1.10M―

Investors

Investor NameFunding Round
Jain FoundationInvestment

Similar Companies

A snapshot of private companies similar to Kinea Bio Inc, helping you discover and navigate related company profiles.

Related News and Analysis